Vanda Pharmaceuticals to Announce Third Quarter 2025 Financial Results on October 29, 2025
Rhea-AI Summary
Vanda Pharmaceuticals (Nasdaq: VNDA) will release its third quarter 2025 financial results on Wednesday, October 29, 2025 after market close.
The company will host a conference call at 4:30 PM ET on October 29, 2025 to discuss the results and corporate activities; domestic dial-in is 1-888-596-4144, international 1-646-968-2525, passcode 8728050. A simultaneous webcast will be available and archived on www.vandapharma.com; investors should access the site at least 15 minutes early to register and install audio software.
A replay will be available beginning October 29, 2025 at 8:30 PM ET through November 5, 2025 at 11:59 PM ET; replay domestic number 1-800-770-2030, international 1-609-800-9909, passcode 8728050.
Positive
- None.
Negative
- None.
News Market Reaction – VNDA
In the Oct 23 session, VNDA gained 2.81%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Call and Webcast to Follow
Vanda will host a conference call at 4:30 PM ET on Wednesday, October 29, 2025, during which management will discuss the third quarter 2025 financial results and other corporate activities. To participate in the conference call, please dial 1-888-596-4144 (domestic) or 1-646-968-2525 (international) and use passcode 8728050.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, October 29, 2025, beginning at 8:30 PM ET and will be accessible until Wednesday, November 5, 2025, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 8728050.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-third-quarter-2025-financial-results-on-october-29-2025-302591878.html
SOURCE Vanda Pharmaceuticals Inc.